What is AZR's dilution risk score?

AZR has a latest available DilutionScore record of 84/100, categorized as critical dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for AZR, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for AZR?

DilutionWatch tracks 25 SEC filing types for AZR including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect AZR shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For AZR, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for AZR tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for AZR. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 8,500+ active tickers monitored.

AZR Stock (ADIAL PHARMACEUTICALS): Dilution Risk 84/100

Score Breakdown

📋 Offering Ability

💰 Cash Runway

📊Float Risk—

⚠️ Warrant Exposure

🔄 Convertible Debt

Dilution Forecast

⛈️

Warning

High probability of dilution event

model est. 37%

📜 Warrant Exercise model 60%

• Massive warrant overhang: 88% of shares outstanding

• Warrant risk score very high (90/100)

💰 Capital Raise model 15%

• Under 12 months cash (10mo)

📉 Score Deterioration model 15%

• Score already CRITICAL (84/100) — events likely imminent

🔔 Track AZR — Get forecast alerts →

Market Data

Market Cap$10.00M

Shares Outstanding2.63M

FloatN/A

Cash$5.88M

DebtN/A

Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

Field	Current Value	Basis
DilutionScore	84/100	DilutionWatch score record
Shares Outstanding	2.63M	Verified float table or market cache
Public Float	Not available	Verified float table or market cache
Market Cap	$10.00M	Market data cache
Cash Runway	9.9 months	DilutionWatch score inputs
Shelf Capacity	None in current score inputs	SEC-derived dilution fields
ATM Capacity	None in current score inputs	SEC-derived dilution fields
Outstanding Warrants	2.30M	SEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 7.

Recent SEC source mix: FORM 4 5, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

AZR SEC Filing Activity — Last 12 Months

Shares outstanding reported by AZR on the cover page of its latest 10-K/10-Q: 2.63M as of August 12, 2026.

DilutionWatch recorded no shelf, registration or prospectus documents for AZR in the last 12 months. Full filing list on SEC EDGAR →

Form	What it is	Filings	Most recent
SC 13G/A	amended passive >5% holder filing	1	Nov 03, 2026
4	insider transaction	4	Nov 04, 2026
3	initial insider ownership	2	Oct 30, 2026

Institutional Holdings

Institutional data not yet available.

Short Interest

No current FINRA short-interest record is available for this ticker.

Recent SEC Activity

xbrl XBRL WARRANT 2026-10-21

xbrl XBRL CONVERTIBLE 2024-04-01

Form 4 INSIDER TRANSACTION 2026-11-02

Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual AZR Dilution Snapshot

ADIAL PHARMACEUTICALS, INC. (AZR) has a DilutionScore of 84/100, rated Critical dilution risk. Score date: November 06, 2026.

Stored outstanding warrants: 2.3M.
Recent SEC activity tracked for AZR: Form 4 on 2026-11-02; Form 4 on 2026-11-02; Form 4 on 2026-11-02.
Score coverage note: Float Risk is excluded because public-float data is unavailable.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

AZR's DilutionScore is currently 84/100 (Critical risk), with 1 score change tracked over 90 days. The score improved from 40/100 (Medium risk).

Period	Score	Risk Level	Duration
Oct 31 – Nov 06, 2026	84/100	CRITICAL	7 days
Aug 09 – Oct 30, 2026	40/100	MEDIUM	83 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Track AZR Dilution Risk in Real-Time

DilutionWatch monitors SEC filings 24/7 and alerts you the moment AZR files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.

Start Tracking AZR — Free

Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — CRITICAL Risk

Other CRITICAL dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,596+ tracked stocks →

📖 Dilution Education

→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations

Score Coverage Note

Float Risk is excluded because public-float data is unavailable.

AZR — ADIAL PHARMACEUTICALS, INC. Dilution Risk Tracker